Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Abuse Potential Study of PF-00345439 [Phase 1]
Phase 1 abuse-potential study of PF-00345439 in opioid users has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Comparative Evaluation of PUSPENs and C&Cs
The clinical trial NCT02698098 evaluating PUSPENs versus C&Cs for opioid use disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone [Phase 2]
Phase 2 clinical trial evaluating whether pioglitazone affects the abuse liability of oxycodone in individuals with opioid use disorder; res…
-
CLINICAL_TRIALS trial_result · 2016-01-11Clinical Trial Update: Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial [Phase 2, Phase 3]
Randomized trial assessing buprenorphine maintenance treatment for opioid dependence in primary care settings, with results posted after com…
-
FDA approval · 2015-12-08FDA Approved: VIVITROL — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for VIVITROL (naltrexone) from Alkermes, Inc., approving changes to labeling and expanding its i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 [Phase 2]
A Phase 2 clinical trial evaluating subanesthetic concentrations of isoflurane and nitrous oxide in individuals with opioid use disorder and…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: Efficacy Evaluation of Traditional Chinese Medicine JITAI Combined Comprehensive Model Among Heroin Addicts After Detoxification [NA]
Clinical trial completed evaluating the efficacy of a Traditional Chinese Medicine JITAI-based model for individuals with opioid use disorde…
-
CLINICAL_TRIALS trial_result · 2015-11-11Clinical Trial Update: Linking Hospitalized Injection Drug Users to Buprenorphine [Phase 3]
Phase 3 clinical trial completion investigating buprenorphine for opioid use disorder in hospitalized injection drug users.
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Pre-Release VIVITROL for Opioid Dependent Inmates [Phase 4]
Phase 4 trial update evaluating VIVITROL for opioid dependence. The study conducted at Rhode Island Hospital has been completed.
-
FDA approval · 2015-10-16FDA Approved: BUPRENORPHINE AND NALOXONE — Original Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved the original application for a generic buprenorphine and naloxone product for the treatment of opioid use disorder.
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: Effects of Diacetylmorphine (DAM) on Brain Function and Stress Response [Phase 1]
Phase 1 study evaluating the effects of diacetylmorphine on brain function and stress response; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Yoga for Pain and Opioid Dependence [Phase 1, Phase 2]
This clinical trial update indicates completed Phase 1 and Phase 2 studies evaluating yoga as an intervention for chronic pain and opioid us…
-
CLINICAL_TRIALS research · 2015-09-24Clinical Trial Update: Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic [NA]
A completed clinical trial from Ohio State University evaluated controlled substance treatment agreements in an internal medicine residency …
-
FDA approval · 2015-09-22FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approved a supplemental application for Suboxone (buprenorphine hydrochloride, naloxone hydrochloride) from Indivior Inc., authorizing c…
-
CLINICAL_TRIALS trial_result · 2015-09-17Clinical Trial Update: Comparison of Two Counseling Induction Strategies [NA]
A completed clinical trial comparing two counseling induction strategies for starting methadone treatment in individuals with opioid use dis…
-
CLINICAL_TRIALS research · 2015-09-04Clinical Trial Update: An Open Label Study of Oral Minocycline for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]
An open-label Phase 3 trial is evaluating oral minocycline for individuals with co-occurring opioid (heroin) and amphetamine dependence. The…
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: An Open-label Study of Oral Paliparidone for the Treatment of Patients With Co-occurring Opioid and ATS Dependence [Phase 3]
An open-label Phase 3 trial evaluating paliparidone for co-occurring opioid use disorder (heroin dependence) and amphetamine use disorder; c…
-
FDA approval · 2015-08-31FDA Approved: METHADONE HYDROCHLORIDE — Original Application (Aurolife Pharma, LLC)
FDA approves the original application (ANDA) for methadone hydrochloride from Aurolife Pharma, LLC (a generic product).
-
CLINICAL_TRIALS trial_result · 2015-08-28Clinical Trial Update: Lofexidine for Inpatient Opiate Detox in Singapore [Phase 4]
The clinical trial update indicates a Phase 4 study of lofexidine for inpatient detoxification in opioid-dependent patients in Singapore has…
-
FDA approval · 2015-08-24FDA Approved: DISKETS — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DISKETS (methadone hydrochloride) from Hikma Pharmaceuticals USA Inc. The action updates the pro…
-
FDA approval · 2015-08-18FDA Approved: METHADONE HYDROCHLORIDE — Original Application (Epic Pharma, LLC)
FDA approved the original application for methadone hydrochloride from Epic Pharma, LLC as a generic drug.
-
FDA approval · 2015-08-17FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride from VistaPharm, LLC, indicating an approved modification to an existing…
-
FDA label_change · 2015-08-10FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
FDA approved a supplemental application for ZUBSOLV, resulting in labeling changes for the buprenorphine/naloxone product from Orexo US, Inc…
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Neurobiology of Opioid Dependence: 1 - 1 [Phase 2]
A Phase 2 trial investigating the neurobiology of opioid dependence sponsored by Yale University has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-07Clinical Trial Update: Neurobiology of Opioid Dependence: 2 - 2 [Phase 2]
A Phase 2 clinical trial on neurobiology of opioid dependence sponsored by Yale University has been withdrawn.